一种用于冠状动脉旁路移植中抗效应的新方法,使用L型和T型通道阻断剂Efonidipine
Xiu-Yun Yin1,2,3, Hai-Tao Hou1,2, Ming-Rui Li1,2
1The Department Cardiovascular Surgery & Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin, China.
Basic & clinical pharmacology & toxicology
|July 8, 2025
概括
埃福尼迪平有效地减少了冠状动脉旁路移植 (CABG) 手术期间的内部乳腺动脉 (IMA) 血管. 这种新药影响L型 (Cav1.2) 和T型 (Cav3.1) 通道,具有优越的抗效果.
科学领域:
- 心血管外科心血管外科
- 药理学 药理学是指药理学的学科.
- 血管生物学 血管生物学
背景情况:
- 内部乳腺动脉 (IMA) 是冠状动脉旁路移植 (CABG) 中首选的移植.
- IMA是已知的并发症,发生在CABG手术的0.43%.
- 埃福尼迪平是一种新型的二皮里丁通道阻塞剂,在IMA中对其抗性质进行了研究.
研究的目的:
- 为了评估efonidipine对人类IMA的抗效应.
- 为了阐明efonidipine抗作用背后的机制.
- 为了比较efonidipine与T型通道阻塞剂的疗效.
主要方法:
- 使用了54名CABG患者的人体IMA样本.
- 为了生成efonidipine的度-放松曲线.
- 分析了Cav1.2和Cav3.1的蛋白质表达,并通过西方 blot.
主要成果:
- 埃福尼迪平证明了与KCl或U46619.19预约的IMA的剂量依赖放松.
- 埃福尼迪平的预治疗显著抑制了血管收缩.
- 埃福尼迪平降低了Cav1.2和Cav3.1蛋白质的表达,显示出比米贝弗拉迪尔更大的疗效.
结论:
- 埃福尼迪平在人体IMA中表现出显著的抗效应.
- 它的机制涉及调节L型 (Cav1.2) 和T型 (Cav3.1) 通道蛋白表达.
- 埃福尼迪平是预防和治疗CABG期间IMA血管的有前途的治疗剂.
相关概念视频
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
702
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
702
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.0K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.0K
Antihypertensive Drugs: Action of Calcium Channel Blockers
784
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
784
Antiepileptic Drugs: Calcium Channel Blockers
640
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
640
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.8K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.8K
Coronary Artery Disease V: Interprofessional Care
38
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
38


